XYL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Xylem Inc. is not a strong buy at the moment for a long-term beginner investor. The technical indicators are bearish, options data reflects negative sentiment, and recent analyst downgrades highlight concerns about growth and project delays. While the company has shown modest financial growth, the lack of immediate positive catalysts and the absence of strong trading signals suggest holding off on investment for now.
The technical indicators for Xylem Inc. are bearish. The MACD is negative and contracting, RSI is neutral at 40.563, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 124.141, with key support at 119.492 and resistance at 128.79.
Additionally, Xylem's Q4 2025 financials showed modest growth in revenue (+6.25% YoY), net income (+2.76% YoY), and EPS (+2.24% YoY).
Technical indicators are bearish, and there is no recent congress trading data or strong Intellectia trading signals.
In Q4 2025, Xylem reported revenue of $2.397 billion (+6.25% YoY), net income of $335 million (+2.76% YoY), EPS of $1.37 (+2.24% YoY), and a gross margin of 38.88% (+2.34% YoY). While the financials show growth, the pace is modest and does not offset concerns about future growth risks.
Recent analyst activity shows mixed sentiment. UBS downgraded the stock to Neutral with a price target of $132, citing near-term growth risks. Other analysts have lowered price targets but maintain Buy or Outperform ratings, with targets ranging from $130 to $175. Concerns about project delays and slower demand weigh on sentiment.
